Stock Price
469.71
Daily Change
3.01 0.64%
Monthly
-4.29%
Yearly
10.72%
Q2 Forecast
459.66

Thermo Fisher Scientific reported $371.62M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
Agilent USD 282.7M 358K Dec/2025
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Bio Techne USD 155.75M 154.18M Sep/2025
Bio-Rad Laboratories USD 26.97M 90K Sep/2025
Boston Scientific USD 1.48B 2.66M Dec/2025
Bruker USD 151.94M 225K Dec/2025
Charles River Laboratories USD 49.22M 2K Dec/2025
Danaher USD 707.7M 800K Mar/2026
Dentsply International USD 199.5M 196.5M Sep/2025
Edwards Lifesciences USD 580.7M 0 Dec/2025
General Electric Aerospace USD 1.04B 5.43M Mar/2026
Henry Schein USD 115.77M 2.8M Dec/2025
Illumina USD 152.8M 900K Dec/2025
Intuitive Surgical USD 355.17M 674K Mar/2026
IQVIA Holdings USD 169.6M 700K Dec/2025
Laboratory Of America USD 82.2M 700K Dec/2025
Medtronic USD 1.28B 1.38M Dec/2025
Mettler Toledo International USD 20.43M 170.6K Dec/2025
Myriad Genetics USD 93.5M 400K Dec/2025
Olympus JPY 1.1B 6.86M Dec/2025
OraSure Technologies USD 70.39M 1.87M Dec/2025
Quest Diagnostics USD 111M 1000K Mar/2026
Repligen USD 56.32M 42K Dec/2025
Revvity USD 113.38M 2.7M Dec/2025
Stryker USD 382.4M 93K Dec/2025
Thermo Fisher Scientific USD 371.62M 4.09M Mar/2026
Veracyte USD 79.05M 377K Dec/2025
Waters USD 98.08M 38.55M Dec/2025
Zimmer Biomet Holdings USD 198.18M 18.44K Dec/2025